Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “GEP-NET”

89 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 89 results

Large-scale testing (Phase 3)Active Not RecruitingNCT04919226
What this trial is testing

Lutetium 177Lu-Edotreotide Versus Best Standard of Care in Well-differentiated Aggressive Grade-2 and Grade-3 GastroEnteroPancreatic NeuroEndocrine Tumors (GEP-NETs) - COMPOSE

Who this might be right for
Neuroendocrine Tumors
ITM Solucin GmbH 259
Not applicableStudy completedNCT03017690
What this trial is testing

Lanreotide and Octreotide Long Acting Release (LAR) for Patients With Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs)

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumor
Ipsen 22
Early research (Phase 1)Not Yet RecruitingNCT07150546
What this trial is testing

Combination External Radiation and PRRT for Large GI Neuroendocrine Tumors.

Who this might be right for
Digestive System Neuroendocrine TumorUnresectable Digestive System Neuroendocrine NeoplasmUnresectable Digestive System Neuroendocrine Tumor G1+1 more
Emory University 15
Very early researchLooking for participantsNCT05359146
What this trial is testing

Combined Beta- Plus Auger Electron Therapy Using a Novel Somatostatin Receptor Subtype 2 Antagonist Labelled With Terbium-161 (161Tb-DOTA-LM3)

Who this might be right for
Neuroendocrine Neoplasia's (NENs)Gastroenteropancreatic Neuroendocrine Tumour (GEP-NET)
University Hospital, Basel, Switzerland 16
Not applicableLooking for participantsNCT07302100
What this trial is testing

Nutritional Status Assessment in Adult Patients Followed for Gastroenteropancreatic Neuroendocrine Tumors at Strasbourg University Hospital

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumor
University Hospital, Strasbourg, France 100
Testing effectiveness (Phase 2)Looking for participantsNCT06505395
What this trial is testing

A Trial to Assess Efficacy, Safety, Pharmacokinetics of Octreotide Subcutaneous Injection in Patients With Gastroentero-pancreatic Neuroendocrine Tumor (GEP-NET)

Who this might be right for
Gastrointestinal Neuroendocrine Pancreatic Tumor
CSPC ZhongQi Pharmaceutical Technology Co., Ltd. 90
Large-scale testing (Phase 3)Active Not RecruitingNCT05050942
What this trial is testing

A Trial to Assess Efficacy and Safety of Octreotide Subcutaneous Depot in Patients With GEP-NET

Who this might be right for
Gastro-enteropancreatic Neuroendocrine Tumor
Camurus AB 332
Not applicableUnknownNCT05448157
What this trial is testing

68Ga-DOTATOC Radio-Guided Surgery With β-Probe in GEP-NET

Who this might be right for
Neuroendocrine Tumor CarcinoidNeuroendocrine Tumor of PancreasGep Net
European Institute of Oncology 20
Not applicableStudy completedNCT02948946
What this trial is testing

Clinical Utility Assay as a Biomarker for Gastroenteropancreatic and Lung Neuroendocrine Tumors

Who this might be right for
Gastroenteropancreatic Neuroendocrine TumorLung Neuroendocrine Neoplasm
H. Lee Moffitt Cancer Center and Research Institute 105
Testing effectiveness (Phase 2)WithdrawnNCT04276597
What this trial is testing

Phase-II Study of Lu177DOTATOC in Adults With STTR(+)Pulmonary, Pheochromocytoma, Paraganglioma, Unknown Primary, Thymus NETs (PUTNET), or Any Other Non-.GEP-NET.

Who this might be right for
Pulmonary Neuroendocrine NeoplasmPheochromocytomaParaganglioma+7 more
Excel Diagnostics and Nuclear Oncology Center
Not applicableStudy completedNCT06853457
What this trial is testing

A Transfer Learning Radiomics Model for Predicting Response to Initial Transarterial Embolization in Patients with Gastroenteropancreatic Neuroendocrine Tumor Liver Metastases

Who this might be right for
Neuroendocrine Tumors, NET
First Affiliated Hospital, Sun Yat-Sen University 257
Testing effectiveness (Phase 2)Active Not RecruitingNCT01841736
What this trial is testing

Pazopanib Hydrochloride in Treating Patients With Progressive Carcinoid Tumors

Who this might be right for
Foregut Neuroendocrine TumorHindgut Neuroendocrine TumorMetastatic Digestive System Neuroendocrine Tumor G1+5 more
National Cancer Institute (NCI) 171
Large-scale testing (Phase 3)Study completedNCT04852679
What this trial is testing

Study to Assess the Efficacy and Safety of Lanreotide Autogel® in Chinese Participants With GEP-NETs

Who this might be right for
Gastroenteropancreatic Neuroendocrine Tumor
Ipsen 43
Testing effectiveness (Phase 2)Ended earlyNCT03042780
What this trial is testing

FOLFIRINOX in Metastatic High Grade Gastroenteropancreatic Neuroendocrine Carcinomas

Who this might be right for
Gastro-enteropancreatic Neuroendocrine TumorPancreatic CancerNeuroendocrine Carcinomas of Pancreas+1 more
H. Lee Moffitt Cancer Center and Research Institute 2
Not applicableStudy completedNCT01476592
What this trial is testing

A Biological Study of Resveratrol's Effects on Notch-1 Signaling in Subjects With Low Grade Gastrointestinal Tumors

Who this might be right for
Neuroendocrine Tumor
University of Wisconsin, Madison 7
Not applicableLooking for participantsNCT06402695
What this trial is testing

Observational Study on GEP-and Pulm-NET Treated at FPG

Who this might be right for
Neuroendocrine TumorsGep NetPulmonary Neuroendocrine Neoplasm
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 650
Early research (Phase 1)Study completedNCT01548482
What this trial is testing

Trebananib And Temsirolimus in Treating Patients With Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Who this might be right for
Adult Solid NeoplasmLung Carcinoid TumorRecurrent Digestive System Neuroendocrine Tumor G1+8 more
National Cancer Institute (NCI) 21
Testing effectiveness (Phase 2)Looking for participantsNCT04837885
What this trial is testing

Intra-arterial Hepatic (IAH) Infusion of Radiolabelled Somatostatin Analogs in GEP-NET Patients With Dominant Liver Metastases

Who this might be right for
Neuroendocrine TumorLiver MetastasesNeuroendocrine Gastroenteropancreatic Tumour
University Hospital, Bordeaux 23
Not applicableStudy completedNCT03288402
What this trial is testing

Investigation of the Effects of Diet on the Measurement of Plasma Chromogranin in NET Patients

Who this might be right for
Neuroendocrine Tumors
University Hospitals Coventry and Warwickshire NHS Trust 346
Testing effectiveness (Phase 2)Study completedNCT04296149
What this trial is testing

Beta- Probe and Surgery in GEP NET: Evaluation of a New Probe

Who this might be right for
Neuroendocrine Tumors
European Institute of Oncology 5
Load More Results